Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)

Clinical and Experimental Immunology

Volumn 118, Issue 1, 1999, Pages 131-136

  Yanagihara, Yasuo ^a   Shiozawa, K ^b   Takai, M ^a   Kyogoku, M ^a   Shiozawa, S ^c  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b National Kakogawa Hospital   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD161; Natural killer T cell; NKR P1; Rheumatoid arthritis; Th1 Th2 imbalance

Indexed keywords

ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CELL DIFFERENTIATION; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KILLER CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

EID: 0032835933     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01018.x     Document Type: Article

References (22)

1. 1 Bix M, Locksley RM. Natural T cells: cells that co-express NKRP-1 and TCR. J Immunol 1995; 155:1020-2.
2. - T cells. J Exp Med 1997; 186:109-20.
3. 3 Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997; 278:1626-9.
4. - T cells in mice and humans. J Exp Med 1994; 180:1097-106.
5. - thymocytes with specific lymphokine secretion. Eur J Immunol 1993; 23:307-10.
6. + T cells upon NKR-P1 cross-linking. J Exp Med 1996; 183:2391-6.
7. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994; 179:1285-95.
8. + T cells produce large amounts of IL-4 and 1FN-γ upon activation by anti-CD3 or CD 1. J Immunol 1997; 159:2240-9.
9. + NTK T cells associated with disease development in autoimmune-prone mice. J Immunol 1996; 156:4035-40.
10. - thymocytes. J Autoimmun 1997; 10:279-85.
11. 11 Sumida T, Sakamoto A, Murata H et al. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med 1995, 182:1163-8.
12. 12 Willson SB, Kent SC, Patton KT et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 1998; 391:177-81.
13. 13 Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91:8562-6.
14. 14 Lanier LL, Chang C, Phillips JH. Human NKR-P1 A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 1994; 153:2417-28.
15. + T cells lose NK1.1 expression upon in vitro activation. J Immunol 1997; 158:5112-9.
16. 16 Shiozawa S, Hayashi S, Tsukamoto Y et al. Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 1998; 10:1891-5.
17. 17 Cornélis F, Fauré S, Martinez M et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998; 95:10746-50.
18. 18 D'Andrea A, Rengaraju M, Valiante NM et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992; 176:1387-98.
19. 19 Chan SH, Perussia B, Gupta JW et al. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991; 173:869-79.
20. 20 Dolhain RJEM, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AMM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1961-9.
21. 21 Van der Graaff WL, Prins APA, Dijkmans BAC, van Lier RAW. Prognostic value of Th1/Th2 ratio in rheumatoid arthritis. Lancet 1998; 351:1931.
22. 22 Makino Y, Koseki H, Adachi Y, Akasaka T, Tsuchida K, Taniguchi M. Extrathymic differentiation of a T cell bearing invariant Vα14Jα281 TCR. Int Rev Immunol 1994; 11:31-46.